Cargando…
Association of BTBD7 with Metastasis and Poor Prognosis in Non-Small-Cell Lung Cancer Patients
Metastasis in lung cancer portends a poor prognosis, and the epithelial-mesenchymal transition (EMT) in lung cancer cells is considered a prerequisite to achieve metastatic potential. Recent studies indicate that BTB/POZ domain-containing protein 7 (BTBD7) regulates EMT-associated proteins in human...
Autores principales: | Luo, Fan-Yan, Liu, Zi-Hou, Hu, Qin-Hua, Lin, Guo-Qiang, Tang, Can-E, Zhang, Wei-Xing, Zhuang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392057/ https://www.ncbi.nlm.nih.gov/pubmed/25874012 http://dx.doi.org/10.7150/jca.11715 |
Ejemplares similares
-
Btbd7 contributes to reduced E-cadherin expression and predicts poor prognosis in non-small cell lung cancer
por: Fan, Chuifeng, et al.
Publicado: (2014) -
High BTBD7 expression positive is correlated with SLUG-predicted poor prognosis in hormone receptor-negative breast cancer
por: Li, Zi-Xiong, et al.
Publicado: (2021) -
The Role of BTBD7 in Normal Development and Tumor
Progression
por: Liu, Yun, et al.
Publicado: (2023) -
Identification of circular RNA BTBD7_hsa_circ_0000563 as a novel biomarker for coronary artery disease and the functional discovery of BTBD7_hsa_circ_0000563 based on peripheral blood mononuclear cells: a case control study
por: Zhou, Hanxiao, et al.
Publicado: (2022) -
BTBD7 Downregulates E-Cadherin and Promotes Epithelial-Mesenchymal Transition in Lung Cancer
por: Shu, Jie, et al.
Publicado: (2019)